Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Nef protein (HIV-1), or Negative Regulatory Factor, is a small 27-35 kDa myristoylated viral accessory protein encoded by HIV-1 and other primate lentiviruses, localizing primarily to the cytoplasm and plasma membrane. It plays a critical role in viral pathogenesis by downregulating cell surface expression of CD4 and MHC class I molecules, thereby evading host immune detection and promoting virus release. Nef also counters host restriction factors like SERINC5 and SERINC3, enhancing virion infectivity by preventing fusion pore enlargement that inhibits viral entry. Additional functions include lowering the activation threshold of CD4+ T cells, retargeting kinases like Lck to endosomes, and inactivating proapoptotic proteins such as Bad to protect infected cells. Early studies debated its role as a transcriptional repressor of the HIV-1 LTR, but this has been largely refuted, with its primary effects on host cell modulation confirmed. Overall, Nef is indispensable for high viral loads in vivo despite not being an enzymatic therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nef protein (HIV-1) (Nef).